Clinical Trials Logo

Filter by:
NCT ID: NCT05071677 Completed - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer

Start date: May 3, 2021
Phase:
Study type: Observational

This study evaluates what influences treatment decision-making in African American women with triple negative breast cancer. The study also aims to learn about the influence of information sources that support this decision-making process.

NCT ID: NCT05071612 Completed - Clinical trials for OSA - Obstructive Sleep Apnea

Parallel Arm Trial of AD109 and AD504 In Patients With OSA

MARIPOSA
Start date: November 29, 2021
Phase: Phase 2
Study type: Interventional

This is a phase 2 randomized double-blind placebo-controlled parallel-arm dose finding study to compare fixed dose combinations of AD109 and AD504 to atomoxetine or placebo in Obstructive Sleep Apnea.

NCT ID: NCT05071586 Completed - Cerebral Palsy (CP) Clinical Trials

Pediatric Teleneuromodulation

Start date: December 21, 2022
Phase: N/A
Study type: Interventional

This study will explore using remotely monitored 'active' non-invasive brain stimulation in children with cerebral palsy. Participants will receive active non-invasive brain stimulation with synchronous safety monitoring and guided instruction with laboratory staff after appropriate training. Participants will be between 8-21 years old and have a diagnosis of hemiparetic cerebral palsy with a history of a perinatal stroke or brain bleed, and can expect to be in the study for 5 days.

NCT ID: NCT05071430 Completed - Panic Disorder Clinical Trials

Safety and Efficacy of HB-1 for Panic Disorder

Start date: February 3, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of HB-1 versus placebo in male and female adult patients aged 18 to 60 years, inclusive, with Panic Disorder.

NCT ID: NCT05071313 Completed - Clinical trials for Respiratory Syncytial Viruses Prevention

A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Start date: October 4, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the immunogenicity and safety of Ad26.RSV.preF-based vaccine and quadrivalent high-dose seasonal influenza vaccine when administered either concomitantly or separately.

NCT ID: NCT05071287 Completed - Weight Loss Clinical Trials

Metabolism of Low Carbohydrate and Ketogenic Diet

Start date: June 3, 2021
Phase: N/A
Study type: Interventional

This study will assess the preliminary efficacy of a lifestyle intervention including low-carb/ketogenic diet and exercise, enhanced by self-monitoring through health technologies on weight and diabetes outcomes (Glucose, HbA1c) and diabetic complications (cognitive function, and renal function) in a 6-month randomized clinical trial in 60 overweight/obese adults with or without T2D. Renal function will be assessed via both traditional and novel biomarkers, including novel metabolites and mitochondrial function.

NCT ID: NCT05071274 Completed - Acne Vulgaris Clinical Trials

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

This single-center, proof of concept trial is being conducted over the course of 42 days followed by a 2-month post-last treatment visit in order to assess the efficacy and tolerability of the Sponsor's SkinPen device in treating Acne Vulgaris on the face.

NCT ID: NCT05071014 Completed - Lung Cancer Clinical Trials

A Study of Pembrolizumab and Cryoablation in People With Mesothelioma

Start date: September 24, 2021
Phase: Phase 1
Study type: Interventional

The researchers are doing this study to find out whether the combination of pembrolizumab and cryoablation is a safe treatment that causes few or mild side effects in people with mesothelioma. The researchers will also look at whether the combination of pembrolizumab and cryoablation is effective against participants' cancer.

NCT ID: NCT05070910 Completed - Cerebral Palsy Clinical Trials

NDT Effectiveness Study

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether there is a functional change in children with Cerebral Palsy (CP) and other neuromuscular disorders participating in Neurodevelopmental Treatment (NDT) intervention using the contemporary practice model (CPM).

NCT ID: NCT05070767 Completed - Headache Clinical Trials

Neurolens Headache Study

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

To understand the benefits of the neurolens Measurement Device and neurolens treatment as it pertains to treating symptoms related to Chronic Headaches. It is a Prospective randomized double masked two arm performed on a minimum of 200 to a maximum of 300 subjects identified as symptomatic (HIT-6 questionnaire score equal to or greater than 56) done across 3-15 clinical sites. There are two subgroups: a minimum of 100 in each subgroup (subgroup 1: pre-presbyopic (18-40 years); subgroup 2: presbyopic subjects (41-60 years).